PURPOSE
To determine whether patients with congenital nystagmus and an anomalous
head posture have better binocular visual acuity than such patients without an
anomalous head posture.
PATIENTS AND METHODS
This was an observational case series of prospectively collected data for 125 patients with clinical and oculographically confirmed congenital nystagmus. Clinical data were tabulated using computer software. Statistical analyses compared binocular visual acuity with and without the presence of a clinically evident anomalous head posture and visual acuity with and without associated sensory disease.
RESULTS
The mean visual acuity was 20/42 (log of the minimal angle of resolution [MAR], 0.32) in patients with an anomalous head posture and 20/83 (logMAR, 0.62) in patients with no anomalous head posture (P < .001). Among patients with disease of the sensory system, those with an anomalous head posture had a mean visual acuity of 20/55 (logMAR, 0.44) and those without an anomalous head posture had a mean visual acuity of 20/108 (logMAR, 0.73; P < .001).
CONCLUSIONS
Visual acuity was found to be significantly better in patients with congenital nystagmus who had an anomalous head posture versus those without such a head posture. Our findings indicate that the presence of an anomalous head posture in a patient with congenital nystagmus correlates with good vision and thus may be considered a positive prognostic sign in a preverbal child.
J Pediatr Ophthalmol Strabismus 2003;40:259-264
AUTHORS
The authors are from the Laboratory of Visual and Ocular Motor
Physiology and the Departments of Ophthalmology, Columbus Children’s
Hospital and The Ohio State University, Columbus, Ohio.
Originally submitted December 4, 2002.
Accepted for publication February 4, 2003.
Address reprint requests to Richard W. Hertle, MD, Pediatric
Ophthalmology Associates, Inc., Children’s Hospital of Columbus, 555 S.
18th Street, Suite 4C, Columbus, OH 43205.
Presented at the Annual Meeting of the American Association for
Pediatric Ophthalmology and Strabismus; March 23-27, 2003; Kamuela, Hawaii.
The authors have no industry relationships to disclose.
In accordance with ACCME policies, the audience is advised that this
continuing medical education activity may contain references to unlabeled uses
of FDA-approved products or to products not approved by the FDA for use in the
United States. The faculty members have been made aware of their obligation to
disclose such usage.
The material presented at or in any SLACK Incorporated continuing
medical education activities does not necessarily reflect the views and
opinions of SLACK Incorporated. Neither SLACK Incorporated nor the faculty
endorse or recommend any techniques, commercial products, or manufacturers. The
faculty/authors may discuss the use of materials and/or products that have not
yet been approved by the U.S. Food and Drug Administration. All readers and
continuing education participants should verify all information before treating
patients or utilizing any product.
